Goddess Gaia Ventures

What Goddess Gaia Ventures does

Goddess Gaia Ventures (GG Ventures) is a London-based venture capital firm that invests in startups operating at the intersection of women's health, sports performance, longevity, and femtech. Founded in 2021 by Priya Oberoi as Europe's first dedicated women's health and performance investment platform, the firm backs AI-native technologies, precision tools, proprietary data flywheels, and machine learning engines purpose-built for female physiology rather than retrofitted from male clinical defaults. The portfolio spans five core verticals — Sports/Strength & Wellness, Longevity & Chronic Diseases, the Seven Female Cancers, Mental Health/HealthTech/Products & Services, and Next Generation Reproductivity — and currently includes 14 portfolio companies with one unicorn exit and two total exits to date.

GG Ventures generates returns through conventional venture fund economics: it raises capital from limited partners and earns management fees plus carried interest on fund performance. The firm is currently in the market with Fund II, having announced a $30M first close in September 2025, following Fund I deployed since 2021. Deal sourcing is supported by a proprietary CRM pipeline tracking more than 500 companies and more than 2,000 pre-vetted opportunities earmarked for investment in the second half of 2025. The firm is FCA-regulated via its appointed representative, Laven Advisors LLP, and is structured as Goddess Gaia Ventures Limited (registered in England, company number 12955017) with offices at 35 Berkeley Square, London. Distribution is concentrated in Europe, with marketing and LP outreach conducted through LinkedIn, Instagram, X, and earned media, including an exclusive Times interview with the Founding General Partner.

Name

Goddess Gaia Ventures

Legal name

Goddess Gaia Ventures Limited

Website

https://ggventures.co.uk

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

Goddess Gaia Ventures is a London-based venture capital firm investing since 2021 in AI-native startups across women's health, sports performance, longevity, and femtech, currently raising a $30M Fund II and managing a 14-company portfolio with one unicorn exit.

Ownership category

akta.pro rank

Product category

Venture Capital

NAICS

All Other Financial Investment Activities (52399), Funds, Trusts, and Other Financial Vehicles (525), Portfolio Management and Investment Advice (523940)

SIC

Investment Advice (6282)

akta.pro primary industry

Gender Lens / Diversity, Equity & Inclusion (DEI) Funds (FSANAJAM)

akta.pro secondary industries

Accelerators & Incubators (Investor-Operated) (FSANAAAM), Micro-VC & Angel Funds (FSANAAAI)

Keywords

• Venture capital investing
• Women's health investing
• Femtech venture capital
• Health tech investments
• Female performance platform

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Venture Capital Fund Management: GG Ventures generates returns through management fees and carried interest from their venture funds. Currently raising Fund II with $30M first close achieved. Returns are realized through portfolio company exits including unicorn outcomes.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Goddess Gaia Ventures is a venture capital firm that raises limited partnership funds from institutional and individual LPs and deploys capital into early-stage startups building AI-native technologies in women's health and female performance. Operating since 2021 via Fund I and currently raising Fund II with a $30M first close, the firm invests across five verticals - sports, strength and wellness; longevity and chronic diseases; seven female cancers; mental health and healthtech; and next generation reproductivity - sourcing proprietary deal flow through a CRM pipeline of more than 500 companies.

Product overview

GG Ventures is Europe's first dedicated women's health and performance venture capital platform. The firm operates across two investment funds (Fund I, established 2021, and Fund II, currently raising), backing AI-native technologies through five core investment verticals: Sports/Strength & Wellness, Longevity & Chronic Diseases, 7 Female Cancers, Mental Health/HealthTech/Products & Services, and Next Gen Reproductivity. The platform leverages a proprietary CRM system with >500 companies in pipeline to identify investment opportunities in precision tools, proprietary data flywheels, and machine learning engines built for women.

Differentiator

Problem solved

Functional benefit

Products and services

• GG Ventures Fund I Founding venture capital fund of Goddess Gaia Ventures, investing in early-stage women's health and performance startups since 2021. Fund I committed capital to the firm's portfolio companies that have produced one unicorn exit and two total exits to date.
• GG Ventures Fund II Successor venture capital fund from Goddess Gaia Ventures, focused on AI-native women's health technologies across the firm's five core verticals. Achieved a $30M first close in September 2025 with deployment sourced from a proprietary pipeline of more than 2,000 pre-vetted opportunities ready for investment in H4 2025.

Quantifiable outcome

• 14 portfolio companies with 1 unicorn exit and 2 total exits

Named customers5 records

Segments6 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Laven Advisors LLPcoreOthersLaven Advisors LLP is Goddess Gaia Ventures' appointed representative. Laven is authorised and regulated by the Financial Conduct Authority (FCA), providing regulatory oversight and compliance framework for GG Ventures' fund management operations.

Scale indicators8 records

Recent moves5 records

Expansion highlights6 records

Direct peers

• SteelSky Ventures: Women's health-focused venture fund that invests specifically across femtech and female consumer health, mirroring GG Ventures' dedicated women's health thesis and portfolio composition.
• Avestria Ventures: Venture fund investing in women's health and female-led businesses across healthcare and consumer, structurally comparable as a small, thesis-driven women's health fund.
• Female Founders Fund: Early-stage fund backing female-founded and women-serving companies, including femtech and consumer health; comparable as one of the longest-running dedicated women-focused venture platforms.
• Portfolia: Investing community and fund structures dedicated to women and women's health, offering a comparable women-centric capital deployment model with deal-flow networks targeting female founders and consumers.
• Emmeline Ventures: Venture fund explicitly focused on women's health across femtech and healthtech stages, the closest thematic peer in terms of mandate and stage focus.

Emerging players

• CrossBay Capital: Emerging fund deploying capital into women's health and femtech, with narrower portfolio and earlier traction but addressing overlapping target companies.

Broad incumbents

• Octopus Ventures: Large UK-based venture platform investing across health, fintech, and deep tech, including notable femtech investments; comparable via overlapping health thesis but broader, sector-agnostic fund mandate.
• LocalGlobe: UK early-stage venture investor backing global technology companies including healthtech; comparable as a European seed investor with overlapping deal-flow but no women-specific mandate.
• Atomico: Pan-European venture firm investing in technology including health and consumer; comparable as a European VC competitor for the same founders and LP relationships.
• Index Ventures: Major global venture firm investing across healthtech and consumer health; relevant as an incumbent increasingly deploying capital into women's health and femtech categories.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/goddessgaiavc
• LinkedInlinkedin.com/company/goddess-gaia-ventures
• Instagraminstagram.com/goddessgaia.ventures

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Goddess Gaia Ventures